Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia. | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

Journal Title: 
Pediatr Transplant
Primary Author: 
Hussein AA
Author(s): 
Hussein AA, Frangoul H
Original Publication Date: 
Sunday, April 14, 2013
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/23581860/

No abstract available.

Bone Marrow Disease(s): 
  • aplastic anemia
Share with addtoany.com.